Acute intermittent porphyria, rasmussen encephalitis, or both?

Barak Tziperman, Ben Zion Garty, Nili Schoenfeld, Vered Hoffer, Nathan Watemberg, Dorit Lev, Yonathan Ganor, Mia Levite, Tally Lerman-Sagie*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

A case of a young woman who suffers from refractory epilepsy in the form of Rasmussen encephalitis and acute intermittent porphyria is presented. The patient developed refractory partial seizures with progressive hemispheric atrophy in the first decade. Both her serum and cerebrospinal fluid contained significantly elevated levels of anti-GluR3B antibodies. Her serum also contained anti-NR2A antibodies (directed against the N-methyl-D-aspartate receptor). Seven years later, acute intermittent porphyria was diagnosed as she developed an acute episode of abdominal pain, dark urine, and hyponatremia. For several years, all attempts to discontinue porphyrinogenic antiepileptic drugs such as phenobarbital and valproate resulted in seizure worsening. During a major acute intermittent porphyria crisis, brain edema and coma developed, allowing the discontinuation of phenobarbital. On recovery, atrophy of the right hemisphere ensued. Several etiologic hypotheses are presented. Double insults, porphyria, and an autoimmune process are suggested for the development of Rasmussen encephalitis in this patient. The authors recommend testing for porphyria in cases of Rasmussen encephalitis and other intractable seizures.

Original languageEnglish
Pages (from-to)99-105
Number of pages7
JournalJournal of Child Neurology
Volume22
Issue number1
DOIs
StatePublished - Jan 2007

Keywords

  • Acute intermittent porphyria
  • Intractable seizures
  • Rasmussen

Fingerprint

Dive into the research topics of 'Acute intermittent porphyria, rasmussen encephalitis, or both?'. Together they form a unique fingerprint.

Cite this